• Recent Posts

  • About Clinical Trials: What They Can Mean For You?
  • The Use of Intent Scale Translations to Predict Purchase Interest
  • Mitigate Medical Product Risk and Improve Safe Use

• REMS Zone

  • FDA approves Exjade to remove excess iron in patients with genetic blood disorder
  • FDA approves Botox to treat overactive bladder
  • FDA approves Octaplas to treat patients with blood clotting disorders
  • FDA permits marketing of first test that can simultaneously identify 11 causes of infectious gastroenteritis
  • FDA requiring lower recommended dose for certain sleep drugs containing zolpidem

BioTrak Research Tel:760.448.4820
Fax: 760.603.9535
contactus@biotrak.com